18194410. COMPOSITIONS AND METHODS FOR TREATING CANCER simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)

COMPOSITIONS AND METHODS FOR TREATING CANCER

Organization Name

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Inventor(s)

Kevan M. Shokat of San Francisco CA (US)

Daniel Gentile of Darien CT (US)

Steven Moss of San Francisco CA (US)

COMPOSITIONS AND METHODS FOR TREATING CANCER - A simplified explanation of the abstract

This abstract first appeared for US patent application 18194410 titled 'COMPOSITIONS AND METHODS FOR TREATING CANCER

Simplified Explanation

The patent application discloses compositions and methods for modulating Ras and treating cancer.

• Ras modulation is a key target for cancer treatment.
• The compositions and methods provided in the patent application offer a novel approach to treating cancer by targeting Ras.
• The innovation aims to improve cancer treatment outcomes by specifically targeting Ras.
• The patent application may lead to the development of new cancer therapies that focus on Ras modulation.

Potential Applications

The technology described in the patent application could potentially be applied in the following areas:

• Cancer treatment
• Drug development targeting Ras modulation
• Precision medicine for cancer patients

Problems Solved

The technology addresses the following problems:

• Lack of effective treatments for Ras-driven cancers
• Limited options for targeting Ras in cancer therapy
• Need for more precise and targeted cancer treatments

Benefits

The technology offers the following benefits:

• Improved outcomes for cancer patients with Ras-driven tumors
• Potential for personalized cancer treatment based on Ras modulation
• Development of novel cancer therapies with increased efficacy

Potential Commercial Applications

The technology could have various commercial applications, including:

• Pharmaceutical companies developing Ras-targeted cancer drugs
• Biotechnology companies focusing on precision medicine for cancer
• Research institutions studying Ras modulation in cancer therapy

Possible Prior Art

One potential prior art in this field is the use of small molecule inhibitors targeting Ras in cancer therapy. However, the specific compositions and methods disclosed in this patent application may offer unique advantages over existing approaches.

Unanswered Questions

How does the technology compare to existing Ras-targeted cancer therapies?

The article does not provide a direct comparison with current Ras-targeted cancer treatments, leaving room for further exploration of the innovation's advantages and limitations.

What are the potential side effects of modulating Ras for cancer treatment?

The potential side effects of Ras modulation in cancer therapy are not addressed in the article, raising questions about the safety and tolerability of the proposed approach.

Original Abstract Submitted

Disclosed herein, inter alia, are compositions and methods for modulating Ras and treating cancer.